NZ245207A - Preparation of prolineboronate esters; peptides with a prolineboronic acid ester at the c-terminus - Google Patents

Preparation of prolineboronate esters; peptides with a prolineboronic acid ester at the c-terminus

Info

Publication number
NZ245207A
NZ245207A NZ24520792A NZ24520792A NZ245207A NZ 245207 A NZ245207 A NZ 245207A NZ 24520792 A NZ24520792 A NZ 24520792A NZ 24520792 A NZ24520792 A NZ 24520792A NZ 245207 A NZ245207 A NZ 245207A
Authority
NZ
New Zealand
Prior art keywords
pyrrolidine
boronic acid
formula
protected
pinanediol
Prior art date
Application number
NZ24520792A
Other languages
English (en)
Inventor
Roger Snow
Terence A Kelly
Julian Adams
Simon Coutts
Clark Perry
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of NZ245207A publication Critical patent/NZ245207A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C07F5/025—Boronic and borinic acid compounds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NZ24520792A 1991-11-22 1992-11-20 Preparation of prolineboronate esters; peptides with a prolineboronic acid ester at the c-terminus NZ245207A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US79614891A 1991-11-22 1991-11-22
US93619892A 1992-08-26 1992-08-26

Publications (1)

Publication Number Publication Date
NZ245207A true NZ245207A (en) 1994-07-26

Family

ID=27121696

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ24520792A NZ245207A (en) 1991-11-22 1992-11-20 Preparation of prolineboronate esters; peptides with a prolineboronic acid ester at the c-terminus

Country Status (17)

Country Link
EP (1) EP0641347A1 (en:Method)
JP (1) JPH07501078A (en:Method)
CN (1) CN1073946A (en:Method)
AU (1) AU661362B2 (en:Method)
CA (1) CA2123128A1 (en:Method)
CZ (1) CZ124494A3 (en:Method)
FI (1) FI942345A0 (en:Method)
HU (1) HUT67937A (en:Method)
IL (1) IL103817A0 (en:Method)
MX (1) MX9206628A (en:Method)
NO (1) NO941905L (en:Method)
NZ (1) NZ245207A (en:Method)
PT (1) PT101079A (en:Method)
SI (1) SI9200332A (en:Method)
SK (1) SK59294A3 (en:Method)
TW (1) TW232697B (en:Method)
WO (1) WO1993010127A1 (en:Method)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6825169B1 (en) 1991-10-22 2004-11-30 Trustees Of Tufts College Inhibitors of dipeptidyl-aminopeptidase type IV
US5965532A (en) * 1996-06-28 1999-10-12 Trustees Of Tufts College Multivalent compounds for crosslinking receptors and uses thereof
US6100234A (en) * 1997-05-07 2000-08-08 Tufts University Treatment of HIV
US6040145A (en) 1997-05-07 2000-03-21 Tufts University Potentiation of the immune response
CN1163594C (zh) 1997-09-29 2004-08-25 尖端医疗有限公司 体外造血细胞的刺激
AU770319C (en) 1998-05-04 2004-11-25 Point Therapeutics, Inc. Hematopoietic stimulation
JP2002517401A (ja) 1998-06-05 2002-06-18 ポイント セラピューティクス， インコーポレイテッド 環状ボロプロリン化合物
US6979697B1 (en) 1998-08-21 2005-12-27 Point Therapeutics, Inc. Regulation of substrate activity
US6890904B1 (en) 1999-05-25 2005-05-10 Point Therapeutics, Inc. Anti-tumor agents
AU2001233622A1 (en) * 2000-02-25 2001-09-03 Novo-Nordisk A/S Inhibition of beta cell degeneration
AU2003218969A1 (en) * 2002-02-01 2003-09-02 Probiodrug Ag Modulation of t lymphocytes using dp iv inhibitors
US7317109B2 (en) 2003-11-12 2008-01-08 Phenomix Corporation Pyrrolidine compounds and methods for selective inhibition of dipeptidyl peptidase-IV
US7767828B2 (en) 2003-11-12 2010-08-03 Phenomix Corporation Methyl and ethyl substituted pyrrolidine compounds and methods for selective inhibition of dipeptidyl peptidase-IV
US7576121B2 (en) 2003-11-12 2009-08-18 Phenomix Corporation Pyrrolidine compounds and methods for selective inhibition of dipeptidyl peptidase-IV
AR046778A1 (es) 2003-11-12 2005-12-21 Phenomix Corp Compuestos heterociclicos de acido boronico. metodos de obtencion y composiciones farmaceuticas.
KR20140089408A (ko) 2003-11-17 2014-07-14 노파르티스 아게 디펩티딜 펩티다제 ⅳ 억제제의 용도
SI1715893T1 (sl) 2004-01-20 2009-12-31 Novartis Pharma Ag Direktna kompresijska formulacija in postopek
TW200604137A (en) 2004-04-27 2006-02-01 Wyeth Corp Coupling process for generating reactive boron-containing derivatives of n-substituted pyrrole-2-carbonitriles to produce biaryls
DOP2006000008A (es) 2005-01-10 2006-08-31 Arena Pharm Inc Terapia combinada para el tratamiento de la diabetes y afecciones relacionadas y para el tratamiento de afecciones que mejoran mediante un incremento de la concentración sanguínea de glp-1
US7399869B2 (en) 2005-05-19 2008-07-15 Genentech, Inc. Fibroblast activation protein inhibitor compounds and methods
US7825139B2 (en) 2005-05-25 2010-11-02 Forest Laboratories Holdings Limited (BM) Compounds and methods for selective inhibition of dipeptidyl peptidase-IV
CN1331835C (zh) * 2005-10-18 2007-08-15 武汉大学 光活性β－羟基酮的制备方法
CA2633803A1 (en) * 2005-12-19 2007-09-07 Trustees Of Tufts College Soft protease inhibitors and pro-soft forms thereof
PE20071221A1 (es) 2006-04-11 2007-12-14 Arena Pharm Inc Agonistas del receptor gpr119 en metodos para aumentar la masa osea y para tratar la osteoporosis y otras afecciones caracterizadas por masa osea baja, y la terapia combinada relacionada a estos agonistas
AU2007238805B2 (en) 2006-04-11 2012-04-05 Arena Pharmaceuticals, Inc. Methods of using GPR119 receptor to identify compounds useful for increasing bone mass in an individual
EP2108960A1 (en) 2008-04-07 2009-10-14 Arena Pharmaceuticals, Inc. Methods of using A G protein-coupled receptor to identify peptide YY (PYY) secretagogues and compounds useful in the treatment of conditons modulated by PYY
EP2730580A1 (en) * 2008-06-17 2014-05-14 Millennium Pharmaceuticals, Inc. Boronate ester compounds and pharmaceutical compositions thereof
AR077642A1 (es) 2009-07-09 2011-09-14 Arena Pharm Inc Moduladores del metabolismo y el tratamiento de trastornos relacionados con el mismo
JP2013523819A (ja) 2010-04-06 2013-06-17 アリーナ ファーマシューティカルズ， インコーポレイテッド Ｇｐｒ１１９レセプターのモジュレーターおよびそれに関連する障害の処置
PH12013500547A1 (en) 2010-09-22 2013-06-10 Arena Pharm Inc Modulators of the gpr119 receptor and the treatment of disorders related thereto
US20140018371A1 (en) 2011-04-01 2014-01-16 Arena Pharmaceuticals, Inc. Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto
WO2012145361A1 (en) 2011-04-19 2012-10-26 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
WO2012145603A1 (en) 2011-04-22 2012-10-26 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
WO2012145604A1 (en) 2011-04-22 2012-10-26 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
WO2012170702A1 (en) 2011-06-08 2012-12-13 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
WO2013055910A1 (en) 2011-10-12 2013-04-18 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
WO2014074668A1 (en) 2012-11-08 2014-05-15 Arena Pharmaceuticals, Inc. Modulators of gpr119 and the treatment of disorders related thereto
US9523687B2 (en) 2014-02-28 2016-12-20 Institut Pasteur Levels of CXCL 10/IP-10 forms and soluble CD26/DPPIV activity as early predictive biomarkers for HIV/SIV associated mucosal inflammation and progression towards AIDS
KR102509950B1 (ko) 2014-05-20 2023-03-14 밀레니엄 파머슈티컬스 인코퍼레이티드 일차 암 치료법 후 사용하기 위한 붕소-함유 프로테아좀 저해제
MX386778B (es) 2015-03-09 2025-03-19 Intekrin Therapeutics Inc Métodos para el tratamiento de enfermedad de hígado graso no alcohólico y/o lipodistrofia.
WO2018162722A1 (en) 2017-03-09 2018-09-13 Deutsches Institut Für Ernährungsforschung Potsdam-Rehbrücke Dpp-4 inhibitors for use in treating bone fractures
CA3058806A1 (en) 2017-04-03 2018-10-11 Coherus Biosciences Inc. Ppar.gamma. agonist for treatment of progressive supranuclear palsy
CN108047257B (zh) * 2017-12-17 2020-03-13 沧州普瑞东方科技有限公司 一种手性n-boc-吡咯烷-2-硼酸的制备工艺
KR102635698B1 (ko) * 2018-02-20 2024-02-14 오츠카 세이야쿠 가부시키가이샤 4-보로노페닐알라닌 제조 방법
CN110452258B (zh) * 2019-09-03 2021-01-01 上海馨远医药科技有限公司 一种二肽缬氨酸硼脯氨酸盐的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4935493A (en) * 1987-10-06 1990-06-19 E. I. Du Pont De Nemours And Company Protease inhibitors
DK0528858T3 (da) * 1990-04-14 1997-07-28 Univ Tufts Med Inhibitorer af dipeptidyl-aminopeptidase type IV
GB9017694D0 (en) * 1990-08-13 1990-09-26 Sandoz Ltd Improvements in or relating to organic chemistry

Also Published As

Publication number Publication date
SK59294A3 (en) 1995-02-08
TW232697B (en:Method) 1994-10-21
NO941905D0 (no) 1994-05-20
HU9401350D0 (en) 1994-08-29
CZ124494A3 (en) 1995-07-12
PT101079A (pt) 1994-02-28
MX9206628A (es) 1993-05-01
SI9200332A (en) 1993-06-30
IL103817A0 (en) 1993-04-04
EP0641347A1 (en) 1995-03-08
AU3136893A (en) 1993-06-15
FI942345A7 (fi) 1994-05-20
WO1993010127A1 (en) 1993-05-27
NO941905L (no) 1994-07-14
HUT67937A (en) 1995-05-29
FI942345A0 (fi) 1994-05-20
AU661362B2 (en) 1995-07-20
JPH07501078A (ja) 1995-02-02
CA2123128A1 (en) 1993-05-27
CN1073946A (zh) 1993-07-07

Similar Documents

Publication Publication Date Title
AU661362B2 (en) Method for making a prolineboronate ester
US5384410A (en) Removal of boronic acid protecting groups by transesterification
KR100939598B1 (ko) 붕소산 에스테르와 산 화합물의 합성
US5462928A (en) Inhibitors of dipeptidyl-aminopeptidase type IV
CA2121369C (en) Inhibitors of dipeptidyl-aminopeptidase type iv
CA2080474A1 (en) Inhibitors of dipeptidyl-aminopeptidase type iv
Wityak et al. Synthesis of thrombin inhibitor DuP 714
EP0724446A1 (en) Electrophilic peptide analogs as inhibitors of trypsin-like enzymes
EP1743676A1 (en) Heterocyclic boronic acid derivatives, dipeptidyl peptidase IV inhibitors
JP2022068192A (ja) 銅およびニッケル触媒による脱炭酸ホウ素化反応
CA2174311A1 (en) Boropeptide inhibitors of thrombin which contain a substituted pyrrolidine ring
Shue et al. Novel methodology for the synthesis of trans-alkene dipeptide isosteres
Demizu et al. Convenient synthesis of an enantiomerically pure bicyclic proline and its N-oxyl derivatives
Lee et al. Efficient synthesis of 3-hydroxyprolines and 3-hydroxyprolinols from sugars
Elgendy et al. Facile routes to 1-halo-1-alkyl boronic esters as precursors for novel thrombin inhibitors
Aggarwal et al. Synthesis of new, highly hindered C2-symmetric trans-(2S, 5S)-disubstituted pyrrolidines
US5543526A (en) 1-amino-4-(1H-imidazole)- aminobutaneboronic acid derivatives, their preparation and use as synthetic intermediates
Taylor et al. The conversion of pentoses to 3, 4-dihydroxyprolines
Hennings et al. Synthesis of (S, S)-and (R, R)-2-amino-3-methylaminobutanoic acid (AMBA)
US5473092A (en) Synthesis of optically-active phosphono analogs of succinates
Peper et al. Utilization of industrial waste materials, 5. Synthesis of new, chiral 1, 3, 2‐oxazaphospholidine‐borane complexes and attempts to apply them in the stereoselective synthesis
US20080261923A1 (en) Alkene Mimics
HK40066099A (en) Synthesis of boronic ester and acid compounds
HK40066099B (en) Synthesis of boronic ester and acid compounds
Choi et al. Preparation of Orthogonally-Protected 3-Methoxy-4-Phosphonomethyl-LPhenylalanine, a New Reagent for the Synthesis of Phosphotyrosyl Mimetic-Containing Peptides